Linee guida Linee guida per la diagnosi e - Cardiologia interventistica

G Ital Cardiol Vol 8 Ottobre 2007
- ESSENCE (Efficacy and Safety of Subcutaneous Enoxaparin
in Non-Q-Wave Coronary Events)
- FRISC (Fast Revascularisation during InStability in Coronary
artery disease)
- FRISC-2 (Fragmin and Fast Revascularisation during InStability
in Coronary artery disease II)
- GRACE (Global Registry of Acute Coronary Events)
- GUSTO (Global Utilization of Streptokinase and t-PA for Occluded
Coronary Arteries)
- GUSTO-2 (Global Use of Strategies To open Occluded coronary
arteries II)
- GUSTO-4 (Global Utilization of Strategies To open Occluded
coronary arteries IV)
- GUSTO-4-ACS (Global Utilization of Strategies To open Occluded
coronary arteries trial IV in Acute Coronary Syndromes)
- HINT (Holland Interuniversity Nifedipine/metopropol Trial)
- HOPE (Heart Outcomes Prevention Evaluation study)
- ICTUS (Invasive versus Conservative Treatment in Unstable
Coronary Syndrome)
- IMPACT-2 (Integrilin to Minimize Platelet Aggregation and
Coronary Thrombosis II)
- INTERACT (Integrilin and Enoxoparin Randomized Assessment
on Acute Coronary Syndrome Treatment)
- IONA (Impact of Nicorandil in Angina)
- ISAR (Intracoronary Stenting and Antithrombotic Regimen)
- ISAR-COOL (Intracoronary Stenting With Antithrombotic
Regimen Cooling-Off)
- ISAR-REACT-2 (Intracoronary Stenting and Antithrombotic
Regimen: Rapid Early Action for Coronary Treatment 2)
- MATE (Medicine vs Angiography in Thrombolytic Exclusion)
- MINAP (National Audit of Myocardial Infarction Project)
- OASIS (Organization to Assess Strategies for Ischaemic Syndromes
pilot study)
- OASIS-5 (Organization to Assess Strategies in Acute Ischemic
Syndromes 5)
- OASIS-6 (Organization for the Assessment of Strategies for
Ischemic Syndromes 6)
- PRISM (Platelet Receptor Inhibition in Ischaemic Syndrome
Management)
- PRISM-PLUS (Platelet Receptor Inhibition in Ischaemic Syndrome
Management in Patients Limited by Unstable Signs
and Symptoms)
- PROVE-IT (Pravastatin or Atorvastatin Evaluation and Infection
Therapy trial)
- PURSUIT (Platelet Glycoprotein IIb/IIIa in Unstable Angina;
Receptor Suppression Using Integrilin Therapy)
- RESTORE (Randomized Efficacy Study of Tirofiban for Outcomes
and Restenosis)
- RITA-3 (Randomized Intervention Trial of unstable Angina 3)
- STEEPLE (The Safety and Efficacy of Enoxaparin In PCI Patients
In International Randomized Evaluation)
- SYNERGY (Superior Yield of the New strategy of Enoxaparin,
Revascularization and Glycoprotein IIb/IIIa inhibitors)
- TACTICS-TIMI-18 (Treat Angina with Aggrastat and Determine
Cost of Therapy with an Invasive or Conservative Strategy)
- TARGET (Tirofiban and Reopro Give Similar Efficacy Outcomes)
- TENACITY (Tirofiban Novel Dosing vs Abciximab with
Evaluation of Clopidogrel and Inhibition of Thrombin Study)
- TIMI (Thrombolysis in Myocardial Infarction)
- TIMI-11A (Thrombolysis in Myocardial Infarction Phase
11A)
- TIMI-11B (Thrombolysis in Myocardial Infarction Phase
11B)
- TIMI-3B (Thrombolysis in Myocardial Ischaemia Phase III)
- VANQWISH (Veterans Affairs Non-Q-Wave Infarction
Strategies in Hospital)
656
Bibliografia
1. Murray CJ, Lopez AD. Alternative projections of mortality
and disability by cause 1990-2020: Global Burden of Disease
Study. Lancet 1997; 349: 1498-504.
2. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E,
Fox KA, Julian D, Lengyel M, Neumann FJ, Ruzyllo W,
Thygesen C, Underwood SR, Vahanian A, Verheugt FW,
Wijns W. Management of acute myocardial infarction in patients
presenting with ST-segment elevation. The Task
Force on the Management of Acute Myocardial Infarction
of the European Society of Cardiology. Eur Heart J 2003;
24: 28-66.
3. Bertrand ME, Simoons ML, Fox KA, Wallentin LC, Hamm
CW, McFadden E, de Feyter PJ, Specchia G, Ruzyllo W.
Management of acute coronary syndromes in patients presenting
without persistent ST-segment elevation. Eur Heart
J 2002; 23: 1809-40.
4. Cook RJ, Sackett DL. The number needed to treat: a clinically
useful measure of treatment effect. BMJ 1995; 310:
452-4.
5. Alpert JS, Thygesen K, Antman EM, Bassand JP. Myocardial
infarction redefined - a consensus document of The
Joint European Society of Cardiology/American College of
Cardiology Committee for the redefinition of myocardial
infarction. Eur Heart J 2000; 21: 1502-13.
6. GRACE Investigators. Rationale and design of the GRACE
(Global Registry of Acute Coronary Events) project: a
multinational registry of patients hospitalized with acute
coronary syndromes. Am Heart J 2001; 141: 190-9.
7. Birkhead JS, Walker L, Pearson M, Weston C, Cunningham
AD, Rickards AF. Improving care for patients with acute
coronary syndromes: initial results from the National Audit
of Myocardial Infarction Project (MINAP). Heart 2004; 90:
1004-9.
8. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ,
Van de Werf F, Goodman SG, Granger CB, Steg PG, Gore
JM, Budaj A, Avezum A, Flather MD, Fox KA. A validated
prediction model for all forms of acute coronary syndrome:
estimating the risk of 6-month postdischarge death in an international
registry. JAMA 2004; 291: 2727-33.
9. Fox KA, Goodman SG, Klein W, Brieger D, Steg PG, Dabbous
O, Avezum A. Management of acute coronary syndromes.
Variations in practice and outcome; findings from
the Global Registry of Acute Coronary Events (GRACE).
Eur Heart J 2002; 23: 1177-89.
10. Hasdai D, Behar S, Boyko V, Danchin N, Bassand JP, Battler
A. Cardiac biomarkers and acute coronary syndromes -
the Euro Heart Survey of Acute Coronary Syndromes Experience.
Eur Heart J 2003; 24: 1189-94.
11. Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK,
Boersma E, Fioretti PM, Simoons ML, Battler A. A
prospective survey of the characteristics, treatments and
outcomes of patients with acute coronary syndromes in Europe
and the Mediterranean basin; the Euro Heart Survey of
Acute Coronary Syndromes (Euro Heart Survey ACS). Eur
Heart J 2002; 23: 1190-201.
12. Hoekstra JW, Pollack CV Jr, Roe MT, Peterson ED, Brindis
R, Harrington RA, Christenson RH, Smith SC, Ohman EM,
Gibler WB. Improving the care of patients with non-ST-elevation
acute coronary syndromes in the emergency department:
the CRUSADE initiative. Acad Emerg Med 2002; 9:
1146-55.
13. Lev EI, Battler A, Behar S, Porter A, Haim M, Boyko V,
Hasdai D. Frequency, characteristics, and outcome of patients
hospitalized with acute coronary syndromes with undetermined
electrocardiographic patterns. Am J Cardiol
2003; 91: 224-7.
14. Stenestrand U, Wallentin L. Early statin treatment following